Soleno Therapeutics (SLNO) stock skyrocketed up over 42% this past week on news that it has achieved a significant milestone with FDA approval ...

After regulators approved Soleno Therapeutics Inc.'s nearly half-million ... in patients with Prader Willi Syndrome, or PWS. The once-a-day tablet — the only drug approved for the 12,000 to ...

PITTSBURGH, March 28, 2025 /PRNewswire/ -- PANTHERx ® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce that it was selected ...